Biocon informs about press release

28 Dec 2020 Evaluate
Biocon has informed that it has enclosed press release titled, ‘Biocon expands generic formulations portfolio with the launch of Tacrolimus capsules in the US’,

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

380.90 12.55 (3.41%)
20-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.45
Dr. Reddys Lab 1298.95
Cipla 1255.85
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×